Brett D Atwater

Summary

Publications

  1. ncbi request reprint Long-term survival using intra-aortic balloon pump and percutaneous right ventricular assist device for biventricular mechanical support of cardiogenic shock
    Brett D Atwater
    Division of Cardiovascular Medicine, University of Wisconsin Madison, 321 S Owen Drive, Madison, WI 53705, USA
    J Invasive Cardiol 20:E205-7. 2008
  2. doi request reprint The immediate impact of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial on the management of stable angina
    Brett D Atwater
    Division of Cardiovascular Medicine, Duke University Medical Center, Durham, North Carolina 27713, USA
    Clin Cardiol 32:E1-3. 2009
  3. doi request reprint Pulmonary vein contraction before and after radiofrequency ablation for atrial fibrillation
    Brett D Atwater
    Division of Cardiovascular Medicine, Department of Internal Medicine, Duke University Medical Center, Durham, North Carolina, USA
    J Cardiovasc Electrophysiol 22:169-74. 2011
  4. doi request reprint Is heart failure guideline adherence being underestimated? The impact of therapeutic contraindications
    Brett D Atwater
    Duke University Medical Center, Durham, NC Durham Veterans Administration Medical Center, Durham, NC Electronic address
    Am Heart J 164:750-755.e1. 2012
  5. doi request reprint Dabigatran for periprocedural anticoagulation following radiofrequency ablation for atrial fibrillation: a meta-analysis of observational studies
    Benjamin A Steinberg
    Duke Center for Atrial Fibrillation, Electrophysiology Section, Duke University Medical Center, Durham, NC, USA
    J Interv Card Electrophysiol 37:213-21. 2013
  6. doi request reprint Impact of using a telescoping-support catheter system for left ventricular lead placement on implant success and procedure time of cardiac resynchronization therapy
    Kevin P Jackson
    Division of Clinical Cardiac Electrophysiology, Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA
    Pacing Clin Electrophysiol 36:553-8. 2013
  7. doi request reprint Implantable cardioverter defibrillators: risks accompany the life-saving benefits
    Brett D Atwater
    Electrophysiology Section, Cardiology Division, Department of Medicine, Duke Clinical Research Institute, Duke University Medical Centre, Durham, NC 27710, USA
    Heart 98:764-72. 2012
  8. doi request reprint Extent of and reasons for nonuse of implantable cardioverter defibrillator devices in clinical practice among eligible patients with left ventricular systolic dysfunction
    Nancy M Allen LaPointe
    Duke University Medical Center, Duke Clinical Research Institute, Durham, NC 27705, USA
    Circ Cardiovasc Qual Outcomes 4:146-51. 2011
  9. doi request reprint Prevalence and clinical characteristics associated with left atrial appendage thrombus in fully anticoagulated patients undergoing catheter-directed atrial fibrillation ablation
    Thomas W Wallace
    Duke Center for Atrial Fibrillation, Cardiac Electrophysiology Section of the Division of Cardiology, Duke University Medical Center, Durham, NC 27710, USA
    J Cardiovasc Electrophysiol 21:849-52. 2010
  10. doi request reprint Usefulness of the Duke Sudden Cardiac Death risk score for predicting sudden cardiac death in patients with angiographic (>75% narrowing) coronary artery disease
    Brett D Atwater
    Duke Clinical Research Institute, Durham, NC, USA
    Am J Cardiol 104:1624-30. 2009

Collaborators

Detail Information

Publications13

  1. ncbi request reprint Long-term survival using intra-aortic balloon pump and percutaneous right ventricular assist device for biventricular mechanical support of cardiogenic shock
    Brett D Atwater
    Division of Cardiovascular Medicine, University of Wisconsin Madison, 321 S Owen Drive, Madison, WI 53705, USA
    J Invasive Cardiol 20:E205-7. 2008
    ..Further evaluation of completely percutaneous biventricular support in acute MI is warranted...
  2. doi request reprint The immediate impact of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial on the management of stable angina
    Brett D Atwater
    Division of Cardiovascular Medicine, Duke University Medical Center, Durham, North Carolina 27713, USA
    Clin Cardiol 32:E1-3. 2009
    ..The impact of these findings on clinical practice remains unknown...
  3. doi request reprint Pulmonary vein contraction before and after radiofrequency ablation for atrial fibrillation
    Brett D Atwater
    Division of Cardiovascular Medicine, Department of Internal Medicine, Duke University Medical Center, Durham, North Carolina, USA
    J Cardiovasc Electrophysiol 22:169-74. 2011
    ....
  4. doi request reprint Is heart failure guideline adherence being underestimated? The impact of therapeutic contraindications
    Brett D Atwater
    Duke University Medical Center, Durham, NC Durham Veterans Administration Medical Center, Durham, NC Electronic address
    Am Heart J 164:750-755.e1. 2012
    ..Several studies based on claims data have reported underutilization of evidence-based heart failure (HF) therapies. The degree to which these estimates fail to account for therapeutic contraindications is unclear...
  5. doi request reprint Dabigatran for periprocedural anticoagulation following radiofrequency ablation for atrial fibrillation: a meta-analysis of observational studies
    Benjamin A Steinberg
    Duke Center for Atrial Fibrillation, Electrophysiology Section, Duke University Medical Center, Durham, NC, USA
    J Interv Card Electrophysiol 37:213-21. 2013
    ..Dabigatran is approved for prevention of stroke or systemic embolism in patients with nonvalvular atrial fibrillation (AF). The safety and effectiveness of periprocedural dabigatran in ablation for AF are unknown...
  6. doi request reprint Impact of using a telescoping-support catheter system for left ventricular lead placement on implant success and procedure time of cardiac resynchronization therapy
    Kevin P Jackson
    Division of Clinical Cardiac Electrophysiology, Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA
    Pacing Clin Electrophysiol 36:553-8. 2013
    ..We sought to evaluate the impact of an LV lead implant approach using telescoping-support catheters (group TS) on success rate, lead location, and procedural time compared to standard over-the-wire implant techniques (group OTW)...
  7. doi request reprint Implantable cardioverter defibrillators: risks accompany the life-saving benefits
    Brett D Atwater
    Electrophysiology Section, Cardiology Division, Department of Medicine, Duke Clinical Research Institute, Duke University Medical Centre, Durham, NC 27710, USA
    Heart 98:764-72. 2012
    ..This commentary summarises the weaknesses, disadvantages and risks of the ICD in a balanced fashion in light of their proven life-saving benefits...
  8. doi request reprint Extent of and reasons for nonuse of implantable cardioverter defibrillator devices in clinical practice among eligible patients with left ventricular systolic dysfunction
    Nancy M Allen LaPointe
    Duke University Medical Center, Duke Clinical Research Institute, Durham, NC 27705, USA
    Circ Cardiovasc Qual Outcomes 4:146-51. 2011
    ..The extent and documented reasons for nonuse of ICDs among patients with left ventricular systolic dysfunction are unknown...
  9. doi request reprint Prevalence and clinical characteristics associated with left atrial appendage thrombus in fully anticoagulated patients undergoing catheter-directed atrial fibrillation ablation
    Thomas W Wallace
    Duke Center for Atrial Fibrillation, Cardiac Electrophysiology Section of the Division of Cardiology, Duke University Medical Center, Durham, NC 27710, USA
    J Cardiovasc Electrophysiol 21:849-52. 2010
    ..Catheter-directed atrial fibrillation (AF) ablation is contraindicated among patients with left atrial appendage (LAA) thrombus. The prevalence of LAA thrombus among fully anticoagulated patients undergoing AF ablation is unknown...
  10. doi request reprint Usefulness of the Duke Sudden Cardiac Death risk score for predicting sudden cardiac death in patients with angiographic (>75% narrowing) coronary artery disease
    Brett D Atwater
    Duke Clinical Research Institute, Durham, NC, USA
    Am J Cardiol 104:1624-30. 2009
    ....
  11. ncbi request reprint Patterns and implications of B-type natriuretic peptide measurement in patients with non-ST-segment elevation acute coronary syndromes
    Brett D Atwater
    University of Wisconsin Madison, Madison, Wisconsin, USA
    Am J Cardiol 100:1727-33. 2007
    ..In conclusion, more widespread measurement of BNP levels for risk stratification of patients with NSTE ACS may be warranted...
  12. ncbi request reprint Fulminant myopericarditis from phenytoin-induced systemic lupus erythematosus
    Brett D Atwater
    Division of Cardiovascular Medicine, Department of Internal Medicine, University of Wisconsin Hospitals and Clinics, Madison, WI 53705, USA
    WMJ 107:298-300. 2008
    ..We present an unusual case of drug-induced lupus from chronic phenytoin use in a man who presented with symptoms of fulminant myopericarditis. To our knowledge, this is the first such case reported in English...
  13. ncbi request reprint Platelet glycoprotein IIb/IIIa receptor antagonists in non-ST segment elevation acute coronary syndromes: a review and guide to patient selection
    Brett D Atwater
    Duke Clinical Research Institute, Durham, North Carolina 27705, USA
    Drugs 65:313-24. 2005
    ....